News

GVK BIO and Aragen Bioscience Sign Definitive Agreement to Acquire Aragen Bioscience, Inc.

The acquisition of Aragen Bioscience provides GVK BIO with world-class expertise in large molecule R&D services and a unique and extensive set of high-content biological services. Combined with GVK BIO’s established small molecule discovery and development capabilities, the acquisition of Aragen Bioscience uniquely positions GVK BIO as a leading provider of integrated R&D services across both large and small molecule platforms and provides a base for further expansion. <MORE

Events

bio-convention-logoBIO 2015

June 15-18
Booth # 3415
Philadelphia, PA

The world’s largest biotechnology gathering, the BIO Exhibition allows exhibitors to reach high-level executives and influential decision makers who come to BIO to discover new players in the industry, form partnerships and evaluate emerging technologies.